Previous Close | 0.5751 |
Open | 0.5600 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 0.5500 - 0.5763 |
52 Week Range | 0.4010 - 2.5500 |
Volume | |
Avg. Volume | 14,682 |
Market Cap | 2.345M |
Beta (5Y Monthly) | 2.79 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.2400 |
Earnings Date | Jul 22, 2024 - Jul 26, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani
Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the Emerging Growth Conference on April 4, 2024 (https://emerginggrowth.com/conference/).
MIAMI, March 06, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 68th Emerging Growth Conference on March 6 & 7, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani